AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
IND Edition 
⚠
✓
Treace Medical Concepts Inc (NASDAQ:TMCI)
4.12 USD
+0.200 5.102%Sponsored Reports
Loading...
| Previous Close (in USD) | 3.92 |
|---|---|
| Change | +0.200 5.102% |
| 52 W H/L (in USD) | 27.410/3.920 |
| EBITDA (in USD) | -50.542M |
| PE Ratio | -- |
| Volume | 792569 |
| Diluted Eps TTM | -0.88 |
| Total Assets (in USD) | 251.907M |
|---|---|
| Total Liabilities (in USD) | 113.969M |
| Revenue TTM (in USD) | 196.031M |
| Cash (in USD) | 12.982M |
| Market Cap (in USD) | 319.962 M |
| Revenue Per Share TTM | 3.181 |
| Gross Profit TTM (in USD) | 114.315M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Employees: 516
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. John T. Treace | CEO, Founder & Director | 1972 |
| 2. | Mr. Thomas E. Timbie | Independent Director | 1958 |
| 3. | Mr. Mark L. Hair CPA | Chief Financial Officer | 1970 |
| 4. | Mr. Aaron Berutti | Sr. VP of Sales | 1979 |
| 5. | Mr. Terry W. Lubben | Sr. VP of Operations | 1965 |
| 6. | Mr. Scot Elder | Chief Legal & Compliance Officer and Corp. Sec. | 1975 |
| 7. | Dr. Sean F. Scanlan Ph.D. | Sr. VP of Marketing | 1982 |
| 8. | Mr. Daniel E. Owens | Chief HR Officer | 1972 |
| 9. | Mr. Jaime A. Frias | Chief Bus. Devel. Officer | 1962 |
| 10. | Ms. Shana Zink | Sr. VP of Clinical Affairs, Medical Education & Reimbursement | NA |
Peers
Sector: Healthcare
Industry: Medical Devices
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ABT
Abbott Laboratories |
+1.950 2.199% | 89.355 | 25.970 | 17.241 | 3.570 | 3.200 | 3.805 | 16.753 |
|
SYK
Stryker Corporation |
+2.640 0.857% | 309.24 | 44.070 | 24.938 | 5.509 | 6.118 | 6.050 | 25.731 |
|
MDT
Medtronic PLC |
+0.940 1.169% | 81.3 | 26.600 | 15.873 | 3.354 | 2.083 | 3.897 | 14.117 |
|
BSX
Boston Scientific Corp |
+0.160 0.342% | 47.25 | 31.490 | 17.241 | 4.407 | 3.650 | 4.878 | 19.194 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|
| Income Before Tax | -42.815M | -20.552M | -3.668M | -4.265M |
| Minority Interest | - | - | - | - |
| Net Income | -47.298M | -24.612M | -6.445M | -5.106M |
| Selling General Administrative | 32.999M | 18.432M | 6.539M | 4.464M |
| Gross Profit | 114.315M | 76.593M | 44.895M | 31.785M |
| Reconciled Depreciation | 2.133M | 0.685M | 1.21M | 0.793M |
| Ebit | -34.844M | -16.51M | -0.891M | -3.535M |
| Ebitda | -31.801M | -15.807M | 0.319M | -2.631M |
| Depreciation And Amortization | 3.043M | 0.703M | 1.21M | 0.904M |
| Operating Income | -34.844M | -16.51M | -0.891M | -3.535M |
| Other Operating Expenses | 176.682M | 110.929M | 56.51M | 42.951M |
| Interest Expense | 4.398M | 4.06M | 2.777M | 0.841M |
| Tax Provision | - | - | - | - |
| Interest Income | 0.91M | 0.018M | - | 0.111M |
| Net Interest Income | -3.488M | -4.042M | -4.523M | -0.73M |
| Income Tax Expense | 4.483M | 4.06M | 2.777M | 0.841M |
| Total Revenue | 141.838M | 94.419M | 57.365M | 39.416M |
| Total Operating Expenses | 149.159M | 93.103M | 44.04M | 35.32M |
| Cost Of Revenue | 27.523M | 17.826M | 12.47M | 7.631M |
| Total Other Income Expense Net | -7.971M | -4.042M | -2.777M | -0.73M |
| Net Income From Continuing Ops | -42.842M | -20.552M | -3.668M | -4.265M |
| Net Income Applicable To Common Shares | -42.815M | -20.748M | -4.308M | -4.905M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 251.907M | 159.024M | 140.821M | 41.807M | 29.716M |
| Intangible Assets | 9.025M | - | - | - | - |
| Other Current Assets | 7.853M | 3.624M | 3.01M | 0.593M | 0.458M |
| Total Liab | 113.969M | 98.495M | 47.748M | 41.031M | 26.555M |
| Total Stockholder Equity | 137.938M | 60.529M | 93.073M | 0.776M | 3.161M |
| Other Current Liab | 31.794M | 21.238M | 14.154M | 0.001M | 6.401M |
| Common Stock | 0.062M | 0.055M | 0.045M | 0.028M | 0.028M |
| Capital Stock | 0.062M | 0.055M | 0.045M | 7.963M | 7.963M |
| Retained Earnings | -134.247M | -84.72M | -41.905M | -21.353M | -17.686M |
| Good Will | 12.815M | - | - | - | - |
| Other Assets | - | 0.146M | - | - | - |
| Cash | 12.982M | 19.473M | 105.833M | 18.079M | 12.139M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 45.033M | 30.245M | 18.21M | 11.598M | 7.332M |
| Current Deferred Revenue | - | - | - | 7.544M | - |
| Net Debt | 57.321M | 49.116M | -76.468M | 12.898M | 7.084M |
| Short Term Debt | 1.404M | 0.339M | - | 1.788M | - |
| Short Long Term Debt | - | - | - | 1.788M | - |
| Short Long Term Debt Total | 70.303M | 68.589M | 29.365M | 30.977M | 19.223M |
| Other Stockholder Equity | 271.96M | 145.221M | 134.933M | 14.166M | 12.884M |
| Property Plant Equipment | - | 15.338M | 2.849M | 0.829M | 1.146M |
| Total Current Assets | 198.359M | 133.402M | 137.972M | 40.978M | 28.57M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | 110.216M | 61.779M | - | - | - |
| Net Receivables | 38.063M | 29.196M | 18.568M | 14.486M | 10.411M |
| Long Term Debt | 53.008M | 52.711M | 29.365M | 29.189M | 19.223M |
| Inventory | 29.245M | 19.33M | 10.561M | 7.82M | 5.562M |
| Accounts Payable | 11.835M | 8.668M | 4.056M | 2.265M | 0.931M |
| Accumulated Other Comprehensive Income | 0.163M | -0.027M | - | -2.636M | -1.641M |
| Non Currrent Assets Other | 0.146M | 0.146M | - | - | - |
| Non Current Assets Total | 53.548M | 25.622M | 2.849M | 0.829M | 1.146M |
| Capital Lease Obligations | 17.295M | 15.878M | - | - | - |
| Long Term Debt Total | - | 52.711M | 29.365M | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|
| Investments | -61.68M | -2.705M | -1.069M | -1.211M |
| Total Cashflows From Investing Activities | -76.518M | -2.705M | -1.069M | -1.211M |
| Total Cash From Financing Activities | 20.806M | 107.652M | 11.503M | 19.739M |
| Net Income | -42.815M | -20.552M | -3.668M | -4.265M |
| Change In Cash | -86.36M | 87.754M | 5.94M | 10.855M |
| Begin Period Cash Flow | 105.833M | 18.079M | 12.139M | 1.284M |
| End Period Cash Flow | 19.473M | 105.833M | 18.079M | 12.139M |
| Total Cash From Operating Activities | -30.648M | -17.193M | -4.494M | -7.673M |
| Depreciation | 2.133M | 0.685M | 1.21M | 0.793M |
| Other Cashflows From Investing Activities | - | - | - | - |
| Dividends Paid | - | -7.935M | - | - |
| Change To Inventory | -8.769M | -3.088M | -3.402M | -2.813M |
| Sale Purchase Of Stock | 2.187M | 7.935M | - | - |
| Other Cashflows From Financing Activities | 52.512M | 1.83M | 31.503M | 19.739M |
| Capital Expenditures | 14.838M | 2.705M | 1.069M | 1.211M |
| Change In Working Capital | -5.809M | -1.33M | -5.319M | -5.308M |
| Other Non Cash Items | 7.732M | 0.176M | 0.221M | 0.147M |
| Free Cash Flow | -45.486M | -19.898M | -5.563M | -8.884M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Vanguard Total Stock Mkt Idx Inv | 2 years ago | 1357644 |
| 2. | Vanguard Small Cap Index | 2 years ago | 1097985 |
| 3. | iShares Russell 2000 ETF | 2 years ago | 1064639 |
| 4. | Xtrackers S&P 500 Swap ETF 1C | 2 years ago | 890000 |
| 5. | Kornitzer Small Cap Equity | 2 years ago | 677733 |
| 6. | Buffalo Small Cap | 2 years ago | 677733 |
| 7. | Vanguard Institutional Extnd Mkt Idx Tr | 2 years ago | 671001 |
| 8. | Emerald Growth A | 2 years ago | 645799 |
| 9. | William Blair Small Cap Growth I | 2 years ago | 627800 |
| 10. | Vanguard Small Cap Growth Index Inv | 2 years ago | 620516 |
| 11. | Empower Small Cap Growth/TimesSquare SP | 2 years ago | 545919 |
| 12. | Fidelity Small Cap Index | 2 years ago | 462272 |
| 13. | Candriam Eqs L Life Care V USD Acc | 2 years ago | 454945 |
| 14. | Principal SmallCap Growth I Instl | 2 years ago | 434104 |
| 15. | iShares Russell 2000 Growth ETF | 2 years ago | 383839 |
| 16. | Belfius Equities Glob Health Care C$ Cap | 2 years ago | 372512 |
| 17. | iShares US Medical Devices ETF | 2 years ago | 290904 |
| 18. | SPDR® S&P Health Care Equipment ETF | 2 years ago | 281406 |
| 19. | State St Russell Sm/Mid Cp® Indx NL Cl C | 2 years ago | 276919 |
| 20. | Fidelity Extended Market Index | 2 years ago | 247940 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Vanguard Group Inc | 2 years ago | 4303399 |
| 2. | BlackRock Inc | 2 years ago | 3691901 |
| 3. | Morgan Stanley - Brokerage Accounts | 2 years ago | 3117734 |
| 4. | Armistice Capital, LLC | 2 years ago | 2400000 |
| 5. | William Blair Investment Management, LLC | 2 years ago | 2329511 |
| 6. | Perceptive Advisors LLC | 2 years ago | 2304954 |
| 7. | Millennium Management LLC | 2 years ago | 2041938 |
| 8. | Atlantic Trust Group, LLC | 2 years ago | 1854916 |
| 9. | Emerald Advisers, LLC | 2 years ago | 1561893 |
| 10. | State Street Corporation | 2 years ago | 1415264 |
| 11. | TimesSquare Capital Management, LLC | 2 years ago | 1384129 |
| 12. | Deutsche Bank AG | 2 years ago | 1265068 |
| 13. | Emerald Mutual Fund Advisers Trust | 2 years ago | 1229128 |
| 14. | Soleus Capital Management, L.P. | 2 years ago | 1014005 |
| 15. | Geode Capital Management, LLC | 2 years ago | 964303 |
| 16. | Next Century Growth Investors LLC | 2 years ago | 769808 |
| 17. | Goldman Sachs Group Inc | 2 years ago | 707044 |
| 18. | NORGES BANK | 2 years ago | 684278 |
| 19. | Kornitzer Capital Management Inc | 2 years ago | 677733 |
| 20. | Candriam Luxembourg S.C.A. | 2 years ago | 454945 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...